The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksARW.L Regulatory News (ARW)

  • There is currently no data for ARW

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Completion of Acquisition

12 Oct 2021 07:00

RNS Number : 7214O
TDR Capital LLP
12 October 2021
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN, INTO OF FROM THE UNITED STATES OF AMERICA, CANADA, JAPAN OR AUSTRALIA OR ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF THAT JURISDICTION

FOR IMMEDIATE RELEASE

12 October 2021

COMPLETION OF ACQUISITION

of

Arrow Global Group plc

by

Sherwood Acquisitions Limited

(a newly formed company owned by investment funds managed by TDR Capital LLP)

 

Sherwood Acquisitions Limited today completed the acquisition of Arrow Global Group plc. The boards of Arrow Global Group plc (the "Company" or "Arrow") and Sherwood Acquisition Limited ("Bidco") reached an agreement on the 31st March 2021 on the terms of a recommended acquisition. Bidco has today acquired the entire issued and to be issued share capital of Arrow (the "Acquisition"). The Acquisition was completed by means of a Court-sanctioned scheme of arrangement under Part 26 of the Companies Act (the "Scheme").

 

The Acquisition values Arrow's entire issued, and to be issued, ordinary share capital at £565 million.

 

TDR Capital LLP has a long track record in the debt portfolio purchase sector, having helped oversee the successful growth of Lowell Group, a debt purchaser of unsecured debt, as its owner from 2011 until 2015. Arrow is a firm that Bidco has followed closely and looks forward to a new chapter in investing in Arrow as a private company.

 

In line with previous guidance issued by Arrow, as new shareholders, Bidco expects net leverage to be within the range of 3.0-3.5 times by 2023. The Acquisition is supported by a £1.5 billion-equivalent debt financing package comprising:

· A £285 million super senior revolving credit facility

· Facility A - €725 million senior secured floating rate 6-year facility

· Facility B - €250 million senior secured fixed rate 5-year facility

· Facility C - £400 million senior secured fixed rate 5-year facility

 

The financing package is underwritten by an arranger group comprising Barclays Bank PLC, J.P. Morgan Chase Bank, N.A, London Branch, Goldman Sachs Bank USA, NatWest Markets Plc, National Westminster Bank plc, Bank of America Europe Designated Activity Company, DNB (UK) Limited, HSBC Bank plc, Citibank N.A. London Branch and Lloyds Bank PLC.

 

 

ENDS

 

For further information please contact

· Andy Smith - Powerscourt - 07872 604 889; andy.smith@powerscourt-group.com

 

 

Forward-looking Information:

Certain information stated in this announcement represents forward-looking statements, within the meaning of the securities laws of certain jurisdictions. By their nature, forward-looking statements involve known and unknown risks and uncertainties because they relate to events and depend on circumstances that may or may not occur in the future. Forward-looking statements are not guarantees of future performance. You should not place undue reliance on forward-looking statements.

Legal Disclaimer:

This announcement relates to the disclosure of information that qualified or may have qualified as inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014.

This announcement does not constitute an offer to sell or the solicitation of an offer to buy any securities, nor shall it constitute an offer, solicitation or sale in the United States or in any jurisdiction in which such offer, solicitation or sale would be unlawful. In particular, neither this announcement nor any copy hereof may be sent or distributed in the United States or to any "U.S. person" (as such term is defined in Regulation S under the U.S. Securities Act of 1933, as amended).

This announcement does not constitute and shall not, in any circumstances, constitute a public offering nor an invitation to the public in connection with any offer within the meaning of Regulation (EU) 2017/1129 (as amended, the "Prospectus Regulation") or the Prospectus Regulation as it forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018 (as amended, the "UK Prospectus Regulation").

This announcement does not constitute an offer of securities to the public in the United Kingdom and is directed solely at persons who are (i) persons having professional experience in matters relating to investments falling within Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (as amended, the "Order"); (ii) high net worth entities falling within Article 49(2)(a) to (d) of the Order; (iii) outside of the United Kingdom; or (iv) persons to whom an invitation or inducement to engage in investment activity (within the meaning of section 21 of the FSMA) in connection with the issue or sale of any securities may otherwise lawfully be communicated or caused to be communicated, all such persons together being referred to as "relevant persons." This communication must not be acted on or relied on by persons who are not relevant persons. Any investment or investment activity to which this communication relates is available only to relevant persons and will be engaged in only with relevant persons. Any person who is not a relevant person should not act or rely on this communication or any of its contents.

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ACQMBBPTMTMBBJB
Date   Source Headline
12th Oct 20217:00 amRNSCompletion of Acquisition
11th Oct 20213:30 pmRNSForm 8.3 - ARWA LN
11th Oct 20213:21 pmRNSHolding(s) in Company
11th Oct 20213:20 pmRNSForm 8.3 - Arrow Global Group Plc
11th Oct 20213:15 pmBUSForm 8.3 - Arrow Global Group plc
11th Oct 20213:14 pmRNSHolding(s) in Company
11th Oct 20212:37 pmRNSForm 8.3 - ARROW GLOBAL GROUP PLC
11th Oct 202112:22 pmRNSScheme of Arrangement becomes Effective
11th Oct 202111:42 amRNSForm 8.5 (EPT/RI)
11th Oct 202111:32 amRNSForm 8.5 (EPT/RI)- Arrow Global Group plc
11th Oct 202110:56 amRNSForm 8.5 (EPT/RI) - Arrow Global Group plc
11th Oct 20219:38 amBUSForm 8.5 (EPT/NON-RI) - ARROW GLOBAL GROUP PLC
11th Oct 20219:36 amRNSForm 8.5 (EPT/RI)
11th Oct 20217:30 amRNSSuspension - Arrow Global Group PLC
8th Oct 20213:26 pmRNSForm 8.3 - ARROW GLOBAL GROUP PLC - Replacement
8th Oct 20213:20 pmRNSForm 8.3 - Arrow Global Group Plc
8th Oct 20213:09 pmRNSForm 8.3 - Arrow Global Group PLC
8th Oct 20211:41 pmRNSHolding(s) in Company
8th Oct 202111:59 amRNSForm 8.5 (EPT/RI) - Arrow Global Group plc
8th Oct 202111:28 amRNSForm 8.5 (EPT/RI)- Arrow Global Group plc
8th Oct 202110:32 amRNSForm 8.5 (EPT/RI)
8th Oct 202110:30 amRNSForm 8.3 - [ARROW GLOBAL GROUP PLC]
8th Oct 202110:14 amBUSForm 8.5 (EPT/NON-RI) - ARROW GLOBAL GROUP PLC
8th Oct 20219:36 amRNSForm 8.5 (EPT/RI)
7th Oct 20215:35 pmRNSForm 8.5 (EPT/RI)-Arrow Global Group plc Amend
7th Oct 20214:41 pmRNSHolding(s) in Company
7th Oct 20214:40 pmRNSHolding(s) in Company
7th Oct 20214:35 pmRNSTotal Voting Rights
7th Oct 20214:34 pmRNSRule 2.9 Announcement
7th Oct 20213:38 pmRNSForm 8.3 - Arrow Global Group PLC
7th Oct 20213:30 pmRNSForm 8.3 - ARWA LN
7th Oct 20213:20 pmRNSForm 8.3 - Arrow Global Group Plc
7th Oct 20213:15 pmBUSForm 8.3 - Arrow Global Group plc
7th Oct 20213:11 pmRNSForm 8.3 - ARROW GLOBAL GROUP PLC
7th Oct 20213:09 pmRNSDirector/PDMR Shareholding
7th Oct 20213:08 pmRNSForm 8.3 - Arrow Global Group PLC
7th Oct 20212:58 pmRNSSanction of Scheme of Arrangement
7th Oct 20212:18 pmRNSUpdate on Debt Financing Arrangements
7th Oct 20212:01 pmRNSForm 8.3 - ARROW GLOBAL GROUP PLC
7th Oct 20211:33 pmBUSForm 8.5 (EPT/NON-RI) - Arrow Global plc - Amendment
7th Oct 202112:57 pmRNSHolding(s) in Company
7th Oct 202111:23 amRNSForm 8.5 (EPT/RI)- Arrow Global Group plc
7th Oct 202110:45 amRNSForm 8.5 (EPT/RI) - Arrow Global Group plc
7th Oct 202110:22 amBUSFORM 8.5 (EPT/NON-RI) - ARROW GLOBAL GROUP PLC
7th Oct 20219:45 amRNSForm 8.3 - Arrow Global Group plc
7th Oct 20219:41 amRNSForm 8.5 (EPT/RI)
7th Oct 20219:32 amRNSForm 8.5 (EPT/RI)-Amendment
7th Oct 20217:00 amRNSForm 8.3 - Arrow Global Group plc
6th Oct 20214:54 pmRNSForm 8.5 (EPT/RI) - Amendment
6th Oct 20213:45 pmBUSForm 8.3 - Arrow Global Group plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.